Annual Operating Expenses
$18.50 M
+$942.10 K+5.37%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual total operating expenses is $18.50 million, with the most recent change of +$942.10 thousand (+5.37%) on December 1, 2023.
- During the last 3 years, RNAZ annual operating expenses has risen by +$17.77 million (+2445.49%).
- RNAZ annual operating expenses is now at all-time high.
Performance
RNAZ Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$2.15 M
-$2.96 M-57.89%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly total operating expenses is $2.15 million, with the most recent change of -$2.96 million (-57.89%) on September 1, 2024.
- Over the past year, RNAZ quarterly operating expenses has dropped by -$3.13 million (-59.24%).
- RNAZ quarterly operating expenses is now -59.24% below its all-time high of $5.28 million, reached on September 1, 2023.
Performance
RNAZ Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
RNAZ Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.4% | -59.2% |
| 3 y3 years | +2445.5% | -7.5% |
| 5 y5 years | +3948.0% | +10000.0% |
RNAZ Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +214.9% | -59.2% | at low |
| 5 y | 5-year | at high | +3948.0% | -59.2% | >+9999.0% |
| alltime | all time | at high | +3948.0% | -59.2% | >+9999.0% |
TransCode Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.15 M(-57.9%) |
| Jun 2024 | - | $5.11 M(+56.8%) |
| Mar 2024 | - | $3.26 M(-19.9%) |
| Dec 2023 | $18.50 M(+5.4%) | $4.07 M(-23.0%) |
| Sep 2023 | - | $5.28 M(+21.9%) |
| Jun 2023 | - | $4.33 M(-9.9%) |
| Mar 2023 | - | $4.81 M(-5.9%) |
| Dec 2022 | $17.55 M | $5.11 M(+18.9%) |
| Sep 2022 | - | $4.30 M(-8.0%) |
| Jun 2022 | - | $4.67 M(+34.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.47 M(+24.1%) |
| Dec 2021 | $5.87 M(+708.3%) | $2.80 M(+20.1%) |
| Sep 2021 | - | $2.33 M(+680.0%) |
| Jun 2021 | - | $298.50 K(-33.6%) |
| Mar 2021 | - | $449.50 K(+18.6%) |
| Dec 2020 | $726.60 K(+59.0%) | - |
| Dec 2020 | - | $379.00 K(+58.2%) |
| Sep 2020 | - | $239.50 K(+161.5%) |
| Jun 2020 | - | $91.60 K(+455.2%) |
| Mar 2020 | - | $16.50 K |
| Dec 2019 | $456.90 K | - |
FAQ
- What is TransCode Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for TransCode Therapeutics?
- What is TransCode Therapeutics annual operating expenses year-on-year change?
- What is TransCode Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly operating expenses year-on-year change?
What is TransCode Therapeutics annual total operating expenses?
The current annual operating expenses of RNAZ is $18.50 M
What is the all time high annual operating expenses for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total operating expenses is $18.50 M
What is TransCode Therapeutics annual operating expenses year-on-year change?
Over the past year, RNAZ annual total operating expenses has changed by +$942.10 K (+5.37%)
What is TransCode Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of RNAZ is $2.15 M
What is the all time high quarterly operating expenses for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total operating expenses is $5.28 M
What is TransCode Therapeutics quarterly operating expenses year-on-year change?
Over the past year, RNAZ quarterly total operating expenses has changed by -$3.13 M (-59.24%)